CIPLA LTD vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of CIPLA LTD (CIPLA) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads CIPLA vs ZYDUSLIFE on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

29.54
P/E ratio
22.83
3.42
P/B ratio
4.09
0.90%
Dividend yield
0.09%
₹48.02
EPS
₹50.09

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

11.60%
Return on equity
21.20%
15.00%
Return on capital
21.00%
21.00%
EBITDA margin
31.00%
13.71%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.37%
Revenue CAGR (3Y)
16.35%
10.88%
Profit CAGR (3Y)
34.80%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.15L Cr
Market cap
₹1.15L Cr
₹28,163 Cr
Revenue
₹27,148 Cr
₹3,862 Cr
Net profit
₹5,124 Cr
0.02
Debt / equity
0.46
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
CIPLA LTD full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

CIPLA LTD vs ZYDUS LIFESCIENCES LTD: Share Price, Valuation & Which to Buy | DocStoX